The US Food and Drug Administration (FDA) has granted Nacuity Pharmaceuticals’ N-acetylcysteine amide tablets (NPI-001) ...

Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other diseases caused by oxidative stress, today announced that ...

Fraud investigator Charette cautioned that not all discrepancies are the result of fraud or criminal conduct. Often, it can be an innocent mistake, such as an error ...

A noted expert on physical education and the importance of movement for young people, Hannah Thompson began as the new NPI ...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) to NPI-001 (N-acetylcysteine amide) tablets, Texas, USA-based clinical-stage biotech Nacuity ...